ISN Amgen prize handed to Giuseppe Remuzzi

At this year’s World Congress of Nephrology, several prizes were given to ISN members including the ISN Amgen award. Giuseppe Remuzzi was the proud recipient of the award this year.

The ISN Amgen International Prize for Therapeutic Advancement in Nephrology was established in 2003 to honor scientists who have increased the understanding and improved the treatment of kidney disease through basic or clinical scientific research leading to therapeutic advances.

As Director of the Division of Nephrology and Dialysis at the Ospedali Riuniti di Bergamo, Remuzzi is the head and founder of the Negri Bergamo Laboratories at the Mario Negri Institute for Pharmalogical Research, Italy.

He also chairs the ISN Global Outreach (GO) Research and Prevention (R&P) Program and his vision has led to a variety of research results from his laboratory contributing to the advancement of nephrology over the last two decades. “As soon as diabetes is diagnosed, kidneys should be protected before they are affected by the disease. Data from our BENEDICT study has shown that this is feasible,” he says.

For more information about the ISN GO R&P Program, click here.

For details on Amgen activities, visit: http://www.amgen.com/